NADA Number: 140-955 | |
| Proprietary Name |
Coban® / Flavomycin® |
|---|---|
| Sponsor |
Elanco Animal Health, A Division of Eli Lilly & Co. |
| Sponsor Address |
Lilly Corporate Center Room 1-23, 12420 Parklawn Drive Indianapolis, IN 46285 USA |
| Ingredients |
Monensin Tylosin Phosphate |
| Species |
Turkey, growing |
| Routes of Administration |
Per Os |
| Dose Form |
Medicated feed |
| Drug Form |
Type A Medicated Article |
| Dispensing Status |
OTC |
| Patent Number |
4366168 4405609 4468380 |
| Withdrawal Time |
Turkey (growing) - zero days before slaughter. |
|
Dosage Amount, Indications & Limitations |
558.355 Monensin. Specifications: Monensin as the base or the sodium salt, contains a minimum of 90 percent monensin activity derived from monensin A and a minimum of 95 percent derived from monensin A plus B. Approvals for Type A medicated articles containing 44, 45 or 60 grams per pound, as monensin sodium. Amount: Monensin, 54 to 90 grams, plus bambermycins, 1 to 2 grams per ton Indications: For the prevention of coccidiosis in turkeys caused by E. adenoeides, E. meleagrimitis, and E. gallopavonis, and for improved feed efficiency in growing turkeys. Limitations: For growing turkeys only. Feed continuously as sole ration. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Amount: Monensin, 54 to 90 grams, plus bambermycins, 2 grams per ton Indications: For the prevention of coccidiosis in turkeys caused by E. adenoeides, E. meleagrimitis, and E. gallopavonis, and for increased rate of weight gain and improved feed efficiency in growing turkeys. Limitations. For growing turkeys only. Feed continuously as sole ration. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Labeling. The labeling of all formulations containing monensin intended for use in turkeys shall bear the following caution statements: Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. Must be thoroughly mixed in feeds before use. Do not feed undiluted. |
| Tolerances |
A tolerance of 0.05 part per million is established for negligible residues of monensin in the edible tissues of cattle and goats. A tolerance for residues of monensin in chickens, turkeys and quail is not needed. Tolerances are established for residues of tylosin in edible products of animals as follows: a. Chickens and turkeys: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. b. Cattle: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. c. Swine: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. d. Milk: 0.05 part per million (negligible residue). e. Eggs: 0.2 part per million (negligible residue). |